Relationship of Cytokines to Symptom Distress and Symptom Clusters Among Non-small-cell Lung Cancer Patients Receiving Gefitinib Treatment: A Pilot Study

Conclusion These results may provide a basis for understanding possible mechanisms of symptom distress in patients with NSCLC; this may possibly lead to the identification of a target for effective symptom management, i.e., focusing on the inflammation pathway for the treatment of detrimental effects of cytokine-induced inflammatory responses.
Source: Journal of Experimental and Clinical Medicine - Category: Journals (General) Source Type: research